31 5月 2018 by admin in UncategorizedComments Zai Lab and Crescendo Biologics Enter Exclusive Worldwide License Agreement for Innovative Protein Therapeutics for Inflammatory Indications
10 5月 2018 by admin in UncategorizedComments Syros Reports First Quarter 2018 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
09 5月 2018 by admin in UncategorizedComments resTORbio Completes Dosing of Patients in Phase 2b Study to Reduce the Incidence of Respiratory Tract Infections in the Elderly
